
|Videos|November 24, 2021
Dr. Chee on novel Optilume device for patients with recurrent anterior urethral stricture
Author(s)Urology Times staff
Advertisement
In this video, Justin Chee, MD, discusses the takeaways and further research of 2 studies he presented at the 2021 International Continence Society Meeting: “The Optilume urethral drug coated balloon for recurrent anterior urethral strictures: 3-year results from the ROBUST I Study,” and “A randomized controlled trial evaluating the Optilume urethral drug coated balloon vs endoscopic management for treatment of recurrent anterior urethral strictures.” Chee is a reconstructive urological surgeon at Murac Health, East Melbourne, Australia.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












